ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/07/11 | 2,093 | 2,113 | 2,087 | 2,108 | +3 | +0.1% | 178,900 |
| 2017/07/10 | 2,115 | 2,115 | 2,085 | 2,105 | +1 | ±0% | 199,600 |
| 2017/07/07 | 2,103 | 2,124 | 2,099 | 2,104 | +1 | ±0% | 235,500 |
| 2017/07/06 | 2,112 | 2,123 | 2,097 | 2,103 | -5 | -0.2% | 222,100 |
| 2017/07/05 | 2,098 | 2,112 | 2,088 | 2,108 | +9 | +0.4% | 226,500 |
| 2017/07/04 | 2,114 | 2,123 | 2,095 | 2,099 | -3 | -0.1% | 272,700 |
| 2017/07/03 | 2,081 | 2,111 | 2,078 | 2,102 | +22 | +1.1% | 336,700 |
| 2017/06/30 | 2,057 | 2,090 | 2,043 | 2,080 | -1 | ±0% | 253,000 |
| 2017/06/29 | 2,080 | 2,082 | 2,058 | 2,081 | +8 | +0.4% | 249,300 |
| 2017/06/28 | 2,039 | 2,079 | 2,020 | 2,073 | +42 | +2.1% | 360,400 |
| 2017/06/27 | 2,018 | 2,038 | 2,011 | 2,031 | +19 | +0.9% | 281,200 |
| 2017/06/26 | 1,989 | 2,018 | 1,985 | 2,012 | +23 | +1.2% | 480,500 |
| 2017/06/23 | 1,989 | 1,998 | 1,972 | 1,989 | ±0 | ±0% | 311,200 |
| 2017/06/22 | 1,965 | 1,993 | 1,965 | 1,989 | +24 | +1.2% | 296,700 |
| 2017/06/21 | 1,967 | 1,988 | 1,950 | 1,965 | -2 | -0.1% | 378,600 |
| 2017/06/20 | 1,927 | 1,988 | 1,927 | 1,967 | +42 | +2.2% | 719,200 |
| 2017/06/19 | 1,909 | 1,940 | 1,880 | 1,925 | +192 | +11.1% | 1,020,400 |
| 2017/06/16 | 1,740 | 1,752 | 1,726 | 1,733 | +1 | +0.1% | 306,700 |
| 2017/06/15 | 1,729 | 1,750 | 1,725 | 1,732 | +8 | +0.5% | 110,000 |
| 2017/06/14 | 1,742 | 1,753 | 1,724 | 1,724 | -17 | -1% | 101,500 |
| 2017/06/13 | 1,742 | 1,752 | 1,733 | 1,741 | +10 | +0.6% | 62,200 |
| 2017/06/12 | 1,748 | 1,750 | 1,726 | 1,731 | -17 | -1% | 67,900 |
| 2017/06/09 | 1,747 | 1,761 | 1,740 | 1,748 | +11 | +0.6% | 115,600 |
| 2017/06/08 | 1,728 | 1,752 | 1,719 | 1,737 | +14 | +0.8% | 101,800 |
| 2017/06/07 | 1,730 | 1,731 | 1,709 | 1,723 | +5 | +0.3% | 105,400 |
| 2017/06/06 | 1,755 | 1,762 | 1,715 | 1,718 | -34 | -1.9% | 77,500 |
| 2017/06/05 | 1,743 | 1,763 | 1,724 | 1,752 | +2 | +0.1% | 85,600 |
| 2017/06/02 | 1,733 | 1,755 | 1,718 | 1,750 | +23 | +1.3% | 90,300 |
| 2017/06/01 | 1,701 | 1,728 | 1,701 | 1,727 | +27 | +1.6% | 52,600 |
| 2017/05/31 | 1,700 | 1,712 | 1,690 | 1,700 | -13 | -0.8% | 67,900 |
| 2017/05/30 | 1,726 | 1,726 | 1,698 | 1,713 | -17 | -1% | 76,900 |
| 2017/05/29 | 1,740 | 1,747 | 1,727 | 1,730 | -12 | -0.7% | 33,100 |
| 2017/05/26 | 1,787 | 1,787 | 1,741 | 1,742 | -45 | -2.5% | 52,600 |
| 2017/05/25 | 1,773 | 1,790 | 1,765 | 1,787 | +12 | +0.7% | 52,500 |
| 2017/05/24 | 1,770 | 1,778 | 1,766 | 1,775 | +13 | +0.7% | 48,000 |
| 2017/05/23 | 1,754 | 1,765 | 1,754 | 1,762 | +6 | +0.3% | 53,900 |
| 2017/05/22 | 1,750 | 1,760 | 1,744 | 1,756 | -4 | -0.2% | 39,400 |
| 2017/05/19 | 1,759 | 1,764 | 1,741 | 1,760 | +1 | +0.1% | 51,200 |
| 2017/05/18 | 1,739 | 1,759 | 1,733 | 1,759 | -7 | -0.4% | 70,400 |
| 2017/05/17 | 1,764 | 1,771 | 1,744 | 1,766 | -8 | -0.5% | 80,400 |
| 2017/05/16 | 1,731 | 1,776 | 1,719 | 1,774 | +65 | +3.8% | 128,500 |
| 2017/05/15 | 1,732 | 1,737 | 1,701 | 1,709 | -48 | -2.7% | 125,800 |
| 2017/05/12 | 1,757 | 1,766 | 1,740 | 1,757 | -16 | -0.9% | 59,400 |
| 2017/05/11 | 1,779 | 1,779 | 1,760 | 1,773 | -1 | -0.1% | 67,200 |
| 2017/05/10 | 1,770 | 1,779 | 1,751 | 1,774 | -6 | -0.3% | 72,900 |
| 2017/05/09 | 1,757 | 1,780 | 1,751 | 1,780 | +29 | +1.7% | 94,300 |
| 2017/05/08 | 1,728 | 1,761 | 1,727 | 1,751 | +39 | +2.3% | 157,800 |
| 2017/05/02 | 1,696 | 1,715 | 1,692 | 1,712 | +22 | +1.3% | 90,800 |
| 2017/05/01 | 1,677 | 1,690 | 1,653 | 1,690 | +16 | +1% | 75,200 |
| 2017/04/28 | 1,700 | 1,706 | 1,673 | 1,674 | -17 | -1% | 96,700 |
1801～
1850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 225,700円 | +13.6% | +29.2% | 2.04% | 11.71倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 475,000円 | +12.0% | +28.1% | 2.53% | 26.18倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 持田薬 | 333,500円 | +3.0% | +27.5% | 2.40% | 21.12倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ネクセラファーマ | 113,300円 | +197.7% | - | 0.00% | 46.30倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,600円 | +3.2% | +4.5% | 3.48% | 17.19倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
